Researchers Identify Key Cells for Blood Sugar Control Using Optogenetics

How does our body control blood sugar so precisely? An international team led by Prof. Nikolay Ninov at the Center for Regenerative Therapies Dresden (CRTD), part of Dresden University of Technology, brought us a step closer to the answer. They found a special group of “first responder” cells in the pancreas that are crucial for triggering blood sugar response. Their findings were published in the journal Science Advances.

Background Research

The research into Optogenetics is a relatively new field of study spanning less than two decades. The basic concept involves using light to control cells in living tissues, particularly neurons that have been genetically modified to respond to light. This has huge potential for treating neurological disorders like Parkinson’s disease or epilepsy.

FAQs

1. **What is the key finding of this research?**
The researchers, led by Prof. Nikolay Ninov at the Center for Regenerative Therapies Dresden (CRTD), part of Dresden University of Technology, have discovered a group of ‚first responder‘ cells in the pancreas which play an integral role in controlling blood sugar levels.

2. **What are these ‚first responder‘ cells?**
These are a special group of cells within the pancreas that react immediately when blood sugar levels fluctuate, signalling other parts of the body to respond appropriately.

3. **What is Optogenetics and how does it relate to this study?**
Optogenetics is a method that uses light to control cells in living tissue which can be genetically adapted to respond precisely as required upon exposure to specific wavelengths of light. In this particular research, optogenetics was used as an investigative tool enabling scientists access deeper understanding on how our body regulates blood sugar.

4. **Why are these findings important?**
Diabetes and other diseases related with abnormal glucose levels are widespread across global populations; understanding exactly how our bodies regulate glucose could eventually lead towards developing more effective treatments or perhaps even avoiding diseased state altogether.

5 **Who will benefit from these findings?**
Predominantly people who suffer from diabetes and medical professionals administering treatment plans will gain from such scientific breakthroughs meanwhile this advancement can also help anyone concerned with maintaining healthy glucose level regulation.

6 .**What further work needs/will be done following this study?**
This research forms one piece in the complex puzzle of understanding human glucose control. Further investigation is required to thoroughly understand inter-cell communication as well as subsequent body responses post receptor cell trigger. Likewise, researchers may also want verify findings across larger population sampling.

7. **When was this study published and where can I find it?**
The study was published in the respected journal ‚Science Advances‘ on July 4th, 2024. For further details you can visit the following link: (http://idw-online.de/de/news836484)

Originamitteilung:

How does our body control blood sugar so precisely? An international team led by Prof. Nikolay Ninov at the Center for Regenerative Therapies Dresden (CRTD), part of Dresden University of Technology, brought us a step closer to the answer. They found a special group of “first responder” cells in the pancreas that are crucial for triggering blood sugar response. Their findings were published in the journal Science Advances.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Bioreactor Allows Automated Long-Term Culturing of Stem Cells

Human induced pluripotent stem cells (hiPSCs) are considered as a promising tool in medicine, with the potential to unlock treatments for many health conditions such as neurodegenerative diseases and disorders. However, producing large amounts of hiPSCs remains a challenge. Researchers from the Fraunhofer Translational Center for Regenerative Therapies TLC-RT at the Fraunhofer Institute for Silicate Research ISC have now developed a bioreactor that can be used for automated long-term culturing of hiPSCs.

Read More

Bioreaktor ermöglicht automatisierte Langzeitkultivierung von Stammzellen

Humane induzierte pluripotente Stammzellen (hiPSCs) gelten als vielversprechendes Werkzeug in der Medizin: Künftig sollen sie die Therapie von vielen Leiden wie etwa neurodegenerativen Erkrankungen ermöglichen. Nach wie vor ist jedoch die Herstellung großer Mengen an hiPSCs eine Herausforderung. Forschende des Fraunhofer-Translationszentrums für Regenerative Therapien TLZ-RT am Fraunhofer-Institut für Silicatforschung ISC haben nun einen Bioreaktor entwickelt, mit dem eine automatisierte Langzeitkultivierung von hiPSCs gelingt.

Read More